Efficacy of a Gamified Augmented Reality Exposure-based Application in Subjects With Fear of Spiders

Not Applicable

Completed

• Conditions: Fear of Spiders
• Interventions: Other: AR app

• Registration Number: NCT04162509
• Lead Sponsor: Prof. Dominique de Quervain, MD

Brief Summary

Investigation of the efficacy of a gamified augmented reality exposure app in individual with fear of spiders.

Detailed Description

The study will be conducted as a randomized controlled between subject trial. The study consists of two visits and a home training for one group. 60 participants between 18 and 40 years with clinical or subclinical fear of spiders will take part in the study.

All assessments of outcome will be conducted on one visit for each participant, including an in vivo BAT. The experimental group will participate in a home training with the app, spanning over two weeks (6x30-minutes sessions), whereas the control group will not receive any treatment (untreated comparison group).

Six weeks after the first visit all participants undergo the assessments of outcome, including a second in vivo BAT. The BAT will take place 4 weeks after completion of the home training. This design allows a direct comparison and therefore an estimation of the efficacy of the gamified AR exposure therapy.

Study Timeline

• Study Start: 2019-10-07
• Study First Submitted: 2019-11-11
• Study First Submitted QC: 2019-11-11
• Study First Posted: 2019-11-14
• Status Verified: 2019-12
• Primary Completion: 2019-12-04
• Study Completion: 2019-12-04
• Last Update Submitted: 2019-12-19
• Last Update Posted: 2019-12-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Fear of spiders
• BAT score before exposure between 1-8
• Physically healthy
• Fluent in German

Exclusion Criteria

• BDI-II sumscore >=20 and/or item 9 >=1
• Concurrent psychotherapy or pharmacotherapy
• Previous exposure-based therapy for spider phobia
• Parallel participation in another study
• Chronic medication intake (except oral contraceptives)
• Medication intake before visits (less than 24h)
• Alcohol intake before visits (less than 12 h)
• Cannabis or other psychoactive substances (including benzodiazepines) intake before visits (less than 5 days)
• For women: Current pregnancy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Exposure	AR app	The experimental intervention in the experimental group consists of six 30-minutes AR exposures as home training (total duration in AR: 3 hours) within two weeks.

Primary Outcome Measures

Name	Time	Method
Subjective fear (SUDS) in the in vivo BAT	6 weeks after day one (4 weeks after completion of home training)	During the BAT participants will be placed in front of a closed room with a spider in it and will be asked to open the door and approach a living house spider measuring about 5 cm, which will be placed in a sealed transparent plastic container on a table at the far end of the room. The participant will be requested to approach the spider and if possible, to touch the container, to remove the lid, insert a hand, and try to pick up and hold the spider for at least 20 s. Pre-defined scores ranging from 0 = refuses to enter the test room to 12 = holds the spider for at least 20 s will be given when the BAT was completed after 3 minutes or terminated by the participant. SUDS for fear and disgust will be taken during the BAT on the same score as on day one, ranging from 0 = no fear to 10 = maximum fear.

Secondary Outcome Measures

Name	Time	Method
Self-reported change in fear of spiders	6 weeks after day one (4 weeks after completion of home training)	For the self-reported change of fear of spiders participants were asked to self-rate their subjective change in fear of spiders on a single visual analogue scale in a range of 0 to 100 (0 = a lot worse, 50 = no change and 100 = a lot better).
Performance Behavioural Approach Test (BAT) in vivo	6 weeks after day one (4 weeks after completion of home training)	See primary outcome for a detailed description.
Clinical rating for specific phobia (DSM-V)	6 weeks after day one (4 weeks after completion of home training)	Fear of spiders will be re-assessed by the section for specific phobia (animal type: spider) of the structured diagnostic interview for mental disorders for DSM-V (DIPS, Schneider \& Margraf, 2017)
Spider Beliefs Questionnaire (SBQ)	6 weeks after day one (4 weeks after completion of home training)	The SBQ assesses specifically spider-related catastrophic cognitions that will be challenged within the exposure sessions and consists of 48 possible thoughts and beliefs in spider situations. Participants evaluate whether they are convinced these beliefs are true while being in a spider situation with a percentage (0 = not at all convinced to 100 = firmly convinced) (Arntz et al. 1993)
Subjective disgust (SUDS) in the in vivo BAT	6 weeks after day one (4 weeks after completion of home training)	See primary outcome for a detailed description.
Fear of spiders Questionnaire (FSQ)	6 weeks after day one (4 weeks after completion of home training)	The FSQ measures avoidance behavior as well as fear of harm and consists of 18 spider relevant situations. Participants evaluate their relationship to spiders on a 7-point Likert-type scale (0 = not at all true to 6 = absolutely true, range 0 - 108) (Szymanski and O'Donohue, 1995)

Trial Locations

Locations (1)

University of Basel; 🇨🇭 Basel, BS, Switzerland